Delivery of 9 Pelvis with Proximal Femurs (L3/L4)- Intact

Closed Solicitation Posted

Solicitation number
FDA24RFQ75F40124R00178
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Silver Spring, Maryland 20993, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The U.S. Food and Drug Administration (FDA) Office of Acquisition and Grant Services is seeking to procure 9 female pelvic cadaver specimens to support the development of optimized female-specific cadaver testing protocols for medical device manufacturers assessing sacroiliac joint fusion devices. The objective is to develop these protocols that can be used to assess the bone-implant integrity of such devices. The specimens must meet specific requirements regarding age, organ evisceration, bone quality, and infectious disease testing. Proposals are due by August 14, 2024 at 3:00 PM ET, and deliveries of 3 specimens at a time are required within 120 days of award. The contract will be a Firm-Fixed Price Purchase Order with a period of performance from September 1, 2024 to August 31, 2025.

This procurement is unrestricted, and the NAICS code is 541715 - Research and Development in the Physical, Engineering, and Life Sciences. The Place of Performance is Silver Spring, MD 20993, USA. No set-aside designations are specified, and the solicitation does not mention any potential incumbents or current contractors. The government has not provided any information about the award value or budget range for this requirement.

Notice text

See the attached SOW.

Files

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors